To explore further the role of VP4 as the rotavirus cell attachment protein, VP7 monoreassortants derived from the sialic-acid-dependent simian strain RRV and from the sialic-acid-independent human strains D, DS-1 and ST-3 were tested for susceptibility of infectivity of neuraminidasetreated MA-104 cells. Infectivity of RRViD VP7 and RRViST-3 VP7 monoreassortants decreased when sialic acid was removed from the cell surface. However, of three separate RRViDS-1 VP7 monoreassortants tested, only one was sialic-aciddependent. Sequence analysis showed that both sialic-acid-independent strains contained a single amino acid change, Lys to Arg, at position 187. In addition, sialic-acid-independent infectivity was seen in one of 14 RRV VP4 neutralization escape mutants tested, and this strain was found to have a Gly to Glu change at amino acid position 150. These results indicate that positions 150 and 187 of VP4 play an important role in early rotavirus-cell interactions.
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The rotavirus virion is composed of three concentric layers of proteins and 11 segments of double-stranded RNA (Both et al., 1994 ; Estes, 1996) . The outermost layer of the virion is comprised of two proteins, VP4 and VP7. VP4 forms dimeric spikes that project from the surface of the virion, which is constituted by VP7 (Shaw et al., 1993 ; Yeager et al., 1994) . Fax j58 2 504 1382. e-mail jeludert!pasteur.ivic.ve Gene 4 encodes VP4 and gene 7, 8, or 9, depending on strain, encodes VP7. VP4 is responsible for the haemagglutination activity of the virion of some strains (Fiore et al., 1991) . Treatment of VP4 with trypsin results in the cleavage of this protein into two polypeptides, VP8* and VP5*, and enhancement of virus infectivity (Clark et al., 1981 ; Espejo et al., 1981 ; Estes et al., 1981) . VP7 is a glycoprotein and constitutes the major outer layer protein (Both et al., 1994 ; Estes, 1996) . Both VP4 and VP7 proteins are capable of inducing neutralizing and protective antibodies (Matsui et al., 1989 ; Conner et al., 1994) .
While most animal rotaviruses require the presence of sialic acid on the cell surface for efficient binding and infectivity, this is not true of the human rotaviruses, nor of a few animal isolates (Fukudome et al., 1989 ; Keljo & Smith, 1988 ; Superti & Donelli, 1991 ; Rolsma et al., 1994) . Me! ndez et al. (1993) isolated a mutant of simian rotavirus, RRV (G3[P3]), whose infectivity was no longer dependent on the presence of sialic acid on the cell surface, and mapped the responsible mutation to gene 4. Recent data using rotavirus reassortants indicated that gene 4 encodes the rotavirus cell attachment protein in both sialic-acid-dependent and -independent strains in vivo as well as in vitro (Ludert et al., 1996) . To investigate further the role of VP4 as an attachment protein, we tested a series of VP7 monoreassortants obtained from sialic-acid-dependent and -independent strains, as well as a series of RRV VP4 escape mutants, for infectivity in neuraminidase-treated MA-104 cells. The results suggest a role for VP4 amino acid positions 150 and 187 in early rotavirus-cell interactions.
A series of VP7 monoreassortants between the simian strain RRV and the human strains D (G1[P8]), DS-1 (G2[P4]) and ) were constructed as previously described (Midthun et al., 1985) . Prior studies have shown that neuraminidase treatment of MA-104 cells reduces the infectivity of RRV up to 90 % (Fukudome et al., 1989 ; Keljo & Smith, 1988 ; Ludert et al., 1996) , while the infectivity of the 0001-5176 # 1998 SGM HCF human strains is unaffected (Fukudome et al., 1989 ; Ludert et al., 1996) . The infectivity of the reassortant strains in neuraminidase-treated MA-104 cells was tested using an assay described previously (Ludert et al., 1996) . In brief, confluent monolayers of MA-104 cells grown in 96-well plates were treated for 1 h with PBS containing 100 mU\ml neuraminidase from Arthrobacter ureafaciens or Vibrio cholerae (Sigma), or PBS as a control. After neuraminidase treatment, cells were washed with PBS and inoculated with serial 10-fold virus dilutions. After incubation overnight, the cells were fixed with methanol and stained for rotavirus focus-forming units (FFU\ml) according to a standard protocol (Bass et al., 1992) . The infectivity obtained in the neuraminidase-treated cells was expressed as a percentage of the infectivity obtained in the control cells. Fig. 1 shows that the infectivity titres of the RRViD VP7 and the RRViST-3 VP7 monoreassortants were reduced Nucleotides and amino acids shown in parentheses relate to the parental RRV strain.
Amino acid position
Amino acid change were not sensitive to neuraminidase treatment of cells ; infectivities ranged between 87 % and 127 % of that obtained in control untreated cells (Ludert et al., 1996 ; E. Me! ndez, personal communication) . These data support previous results from our laboratory which indicated that the differences in neuraminidase-dependent infectivity between strains co-segregate with the parental origin of gene 4, not gene 9 encoding VP7 (Ludert et al., 1996) . However, the infectivity of two independently propagated RRViDS-1 VP7 reassortants (called here A and B for clarity) was not affected by the neuraminidase treatment of the cell (Fig. 1) . To confirm this result, the infectivity in neuraminidase-treated cells of a third RRViDS-1 VP7 reassortant (called C) from a different source was also tested. All three strains of RRViDS-1 were isolated from the same original mixed infection, although each strain had been maintained in a different laboratory for several years. Unexpectedly, the third RRViDS-1 VP7 reassortant (C) showed a dependence of its infectivity on sialic acid similar to RRV (Fig. 1) . We sequenced the fourth genes of the three RRViDS-1 VP7 reassortant strains in an attempt to resolve this discrepancy. The entire VP4 coding regions were sequenced using a strategy described by Ward et al. (1997) ; internal primers were used to amplify by PCR and to sequence several overlapping fragments, so that both strands were sequenced without requiring cloning. Sequence comparison with the sialic-acid-dependent strain and the parental strain RRV showed that both sialic-acid-independent strains contained a single amino acid change of a Lys to an Arg at position 187 (Table 1) . In addition, all three strains showed two more changes in relation to the parental strain RRV, at position 37 (Leu to Pro) and at position 267 (Tyr to Cys). These last two changes were also present in the sialic-acid-dependent reassortant RRViD VP7 (Table 1) . Therefore, only the Mutations that affect rotavirus VP4 Mutations that affect rotavirus VP4 change at position 187 co-segregated with the altered phenotype. Sequence analysis showed no substitutions in any of the three reassortant VP7 genes, compared with the parental DS-1 VP7 gene (data not shown).
The sialic-acid-independent RRViDS-1 VP7 reassortants were still capable of haemagglutinating human type O red blood cells (RBC) and this property was abolished if the RBC were treated with V. cholerae neuraminidase (data not shown). Furthermore, none of the reassortants showed altered reactivity compared to RRV when tested in a haemagglutination inhibition assay against a series of monoclonal antibodies (MAb) which mapped at positions 87, 88, 89, 100, 114, 133, 135, 148, 150 and 188 in VP8*, and three MAb which mapped at positions 388, 393 and 393 in VP5* (Mackow et al., 1988 ; Giammaroli et al., 1996 ; data not shown).
To study further the nature of sialic-acid-dependent binding of rotavirus to MA-104 cells, the infectivity of a series of independent RRV VP4 MAb escape mutants was also tested in neuraminidase-treated cells (Mackow et al., 1988 ; Giammaroli et al., 1996) . The infectivity of most of the escape mutants tested was reduced between 80 % and 90 % in cells treated with A. ureafaciens neuraminidase, similar to the reduction in infectivity obtained with the parental virus RRV. However, the infectivity of variant 5C4 (v.5C4), with a Gly to Glu change at amino acid position 150, was no longer sialic-acid-dependent (Fig. 2) . These results suggest a role for this position in the binding of rotaviruses to cells. Variant 5C4 retained haemagglutination activity, which was abolished when the RBC were treated with neuraminidase (data not shown). Interestingly, v.7A12 with a mutation adjacent to position 187 (position 188), showed sialic-acid-dependent infectivity similar to the parental RRV (Fig. 2) .
Recent data from our laboratory using rotavirus reassortants indicated that gene 4 encodes the rotavirus cell attachment protein. We have now obtained data which indicate that positions 150 and 187 of VP4 play a critical role in the early interactions between the virus and the cell. Me! ndez et al. (1993) isolated RRV variants whose infectivity was no longer sialic-acid-dependent. Sequence analysis showed that the variants carried mutations with respect to RRV at positions 37 (Pro to Leu), 187 (Lys to Arg) and 267 (Cys to Tyr). Characterization of revertant strains which regained sialic acid dependence (Me! ndez et al., 1996) showed that the amino acid at position 187 changed back to Lys. Our results are in close agreement with those obtained by Me! ndez et al. (1993 Me! ndez et al. ( , 1996 in that a Lys at position 187 is associated with a sialic-aciddependent phenotype while an Arg at this position is associated with a neuraminidase-independent phenotype. However, position 187 is located within a VP8* highly variable region (Larralde et al., 1991) , and the Lys at this position in RRV is not conserved in other sialic-acid-dependent animal strains (Isa et al., 1997) .
The sialic-acid-independent RRV mutants isolated by Me! ndez et al. (1996) had VP4 sequences identical to the VP4 of their reassortant virus parent (RRViDS-1) despite the fact that the RRViDS-1 reassortant did not show a sialic-acidindependent phenotype. This led Me! ndez et al. (1996) to propose that VP7 plays a role in determining the VP4 mutant phenotype observed. However, our data do not support this conclusion. All three of our RRViDS-1 VP7 monoreassortants carry DS-1 VP7 and RRV VP4, but only two of them express the altered phenotype. In addition, the infectivity of a RRViDS-1 VP4 monoreassortant, containing only VP4 from RRV, was sialic-acid-dependent as would be expected if DS-1 VP7 did not directly affect VP4 sialic acid binding (data not shown). Furthermore, v.5C4 only carries RRV proteins but is sialic-acid-independent. Our data with the RRViDS-1 reassortants, and in particular with v.5C4, clearly indicate that HCH amino acid changes in the sequence of VP4 alone are sufficient to alter the sialic-acid-dependent phenotype of the virus.
We could not detect any change in antigenicity, as assessed by haemagglutination inhibition, in the VP4 of the sialic-acidindependent RRViDS-1 VP7 reassortants using a panel of 13 MAb available against VP8* or VP5*. Similar results were obtained by Me! ndez et al. (1993 Me! ndez et al. ( , 1996 although with a less extensive MAb panel. In addition, the sialic-acid-dependent haemagglutination activity manifested by the sialic-acidindependent strains strongly suggests that these variant strains still retain the ability to recognize and bind to sialic acid. It is not known whether the site of VP4 that binds sialic acid on the erythrocyte receptor is the same site that binds sialic acid on the cell surface. However, the haemagglutinin domain of rotaviruses has been mapped to the region between positions 97 and 208 (Fuentes-Panana! et al., 1995) , a region that contains both mutations mapped in this paper. These results indicate that, despite the change in the sialic acid binding phenotype of RRViDS-1 VP7 reassortants A and B and v.5C4, the functional structure of their VP4 was not substantially altered.
We have mapped two positions (amino acids 150 and 187) in the VP4 primary sequence in which single amino acid mutations alter the infectivity phenotype of RRV VP4 from sialic-acid-dependent to sialic-acid-independent. Both positions seem to play a key role in the early steps of rotavirus-cell interactions. However, these variants still retain their ability to recognize sialic acid, at least on RBC. Thus, positions 150 and 187 may not necessarily be part of the actual sialic acid binding site on VP4. Recent findings suggest that amino acids at positions 155, 188 and 190 interact directly with the sialic acid molecule (Isa et al., 1997) . We favour the idea that the mutants described have undergone conformational changes in VP4 that render their infectivity sialic-acid-independent. Our results are consistent with the model of multistep binding for rotavirus proposed by Me! ndez et al. (1993) . We hypothesize that upon virus binding to sialic acid, VP4 undergoes a conformational change that allows for virus recognition, either via VP4 itself or with VP4 and VP7, of a putative secondary receptor on the cell surface. Coulson et al. (1997) recently identified recognition sites for integrins on both VP4 and VP7 rotavirus proteins. The neuraminidase-resistant variants, although still able to bind to sialic acid, no longer require this step to proceed to the next phase of the infectious cycle. Reversible conformational changes upon attachment to sialic acid have recently been detected in the protein σ1 of reovirus (Fernandes et al., 1994) , a protein with many similarities to VP4. We are currently testing the hypothesis that VP4 undergoes conformational changes upon binding to sialic acid.
